Differential expression of matrix metalloproteinases and miRNAs in the metastasis of oral squamous cell carcinoma

BMC Oral Health

Table 1 Clinical characteristic of the oral squamous cell carcinoma (OSCC) patients used for microarray assay and qRT-PCR

NO.	Tumor statue	Age range (years)	Site	Clinical stage	TNM classification	Application
1	Nonmetastatic	40–49	Tongue	II	T2N0M0	Microarray assay
2	Nonmetastatic	60–69	Oral floor	III	T3N0M0	Microarray assay
3	Nonmetastatic	40–49	Tongue	II	T2N0M0	Microarray assay
4	Nonmetastatic	60–69	Gingiva	II	T2N0M0	Microarray assay
5	Nonmetastatic	40–49	Tongue	IV	T4N0M0	Microarray assay
6	Nonmetastatic	50–59	Buccal mucosa	III	T3N0M0	Microarray assay
7	Metastatic	50–59	Tongue	III	T2N1M0	Microarray assay
8	Metastatic	60–69	Tongue	IV	T2N2M0	Microarray assay
9	Metastatic	40–49	Tongue	IV	T1N2M0	Microarray assay
10	Metastatic	60–69	Tongue	IV	T2N2M0	Microarray assay
11	Metastatic	50–59	Tongue	IV	T2N2M0	Microarray assay
12	Metastatic	50–59	Buccal mucosa	IV	T1N2M0	Microarray assay
13	Nonmetastatic	50–59	Tongue	II	T2N0M0	qRT-PCR
14	Nonmetastatic	40–49	Tongue	II	T2N0M0	qRT-PCR
15	Nonmetastatic	60–69	Buccal mucosa	II	T2N0M0	qRT-PCR
16	Nonmetastatic	40–49	Gingiva	II	T2N0M0	qRT-PCR
17	Nonmetastatic	30–39	Tongue	II	T2N0M0	qRT-PCR
18	Nonmetastatic	60–69	Gingiva	III	T3N0M0	qRT-PCR
19	Nonmetastatic	70–79	Tongue	III	T3N0M0	qRT-PCR
20	Nonmetastatic	50–59	Tongue	IV	T4N0M0	qRT-PCR
21	Metastatic	50–59	Buccal mucosa	IV	T1N2M0	qRT-PCR
22	Metastatic	70–79	Tongue	IV	T2N2M0	qRT-PCR
23	Metastatic	60–69	Tongue	IV	T2N2M0	qRT-PCR
24	Metastatic	60–69	Tongue	IV	T2N2M0	qRT-PCR
25	Metastatic	50–59	Oral floor	IV	T1N2M0	qRT-PCR
26	Metastatic	50–59	Buccal mucosa	IV	T4N1M0	qRT-PCR
27	Metastatic	40–49	Tongue	IV	T3N1M0	qRT-PCR

ISSN: 1472-6831